Legend Biotech’s Post

Our LEGENDs in Ghent, Belgium, embody the phrase “one Legend” and often observe special occasions as a team. Recently, they celebrated the summer solstice together. Team building is a favorite pastime at Legend. Would you like to join our growing team? Click here to see our current openings. https://lnkd.in/e-rXFgQq #WeAreLegend

#LegendNews: As we continue our pursuit to transform patients’ lives, we are pleased to announce a positive interim analysis from our Phase 3 #MultipleMyeloma study.    Read the topline results: https://bit.ly/4cNaxHt   #CellTherapy 

Explore our state-of-the-art CAR-T Cell processing facility at Tech Lane in Ghent, Belgium.    As the demand for our #CellTherapy increases, we are scaling up our capabilities and streamlining our manufacturing processes to expand capacity and meet patients’ needs.     Learn more about our approach: https://lnkd.in/eNs5VmNJ     #Biotech #CART  

In an interview with Pharmaceutical Executive, our CEO, Ying Huang, discusses the promising potential of CAR-T therapies as they move up the #MultipleMyeloma treatment paradigm.     Click here to read the article and learn more about our latest data presented at #ASCO24: https://lnkd.in/eer3kCSx

Legend Biotech was featured in Scientific American, where we discussed the success of CAR-T cell therapies in transforming the treatment paradigm for #MultipleMyeloma.  Learn how we are racing to treat more patients faster: https://lnkd.in/eC_iEmMc #CellTherapy #CART

We are excited to share the latest data from our #MultipleMyeloma studies at the European Hematology Association (EHA)’s Congress in Madrid this weekend. Attending the meeting? Click for details on our oral and four poster presentations: https://bit.ly/3R3DeaO  #EHA2024 #CellTherapy 

We are #hiring! Our growing global team aims to transform the #CellTherapy landscape in hematology and oncology. Meet our colleagues in Belgium and hear how their passion for patients is driving our transformational science.    Interested in working alongside LEGENDary teams? Find open roles across our offices at https://lnkd.in/e-rXFgQq.  #Biotech #JoinOurTeam 

Our Head of Manufacturing Sciences & Technology (MS&T), Pieter Jacobs, was part of an esteemed panel organized by EP PerMed - the European Partnership for Personalised Medicine that brainstormed ways to expedite the production of personalized medicines.   The roundtable focused on the immediate need to attract top talent and support ingenuity that drives advances in technology and manufacturing.  Legend Biotech is proud to be leading the development of cell therapy technology in Europe.      #EPPerMed #PersonalisedMedicine #CellTherapy #CART 

Our CEO, Ying Huang, sat down with Alaric DeArment while at #ASCO24 to discuss our latest #MultipleMyeloma data and efforts to expand the geographic reach of our CAR-T therapy.    Through a pilot program with the University of Pennsylvania, we hope to bring our #CART therapy to more patients by broadening availability to regional oncology centers affiliated with the institution.     Read the full article on Scrip: https://bit.ly/3RcZ5gi        #CellTherapy